{
    "2020-11-01": [
        [
            {
                "time": "",
                "original_text": "医药行业每周医览药闻：医药零售板块2020年三季报业绩总结：抓住景气度提升明确的优质赛道",
                "features": {
                    "keywords": [
                        "医药行业",
                        "零售板块",
                        "三季报",
                        "业绩总结",
                        "景气度提升",
                        "优质赛道"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601)：受四联苗新剂型招标进度影响 全年仍有望实现稳定增长",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联苗",
                        "新剂型",
                        "招标进度",
                        "稳定增长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}